These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9875428)
1. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim HH; Kim YM; Han SK Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim YM J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Kim HH; Kong HS; Kim YM Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682 [TBL] [Abstract][Full Text] [Related]
5. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim YM J Pharm Sci; 2001 Nov; 90(11):1767-75. PubMed ID: 11745734 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy. Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine. Kim H; Kim D; Choi D; Jeon H; Han J; Jung Y; Kong H; Kim YM Drug Deliv; 2008 Jan; 15(1):37-42. PubMed ID: 18197522 [TBL] [Abstract][Full Text] [Related]
9. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis. Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354 [TBL] [Abstract][Full Text] [Related]
11. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid. Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis. Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Lee JS; Jung YJ; Doh MJ; Kim YM Drug Dev Ind Pharm; 2001 Apr; 27(4):331-6. PubMed ID: 11411900 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS). Cai QX; Zhu KJ; Chen D; Gao LP Eur J Pharm Biopharm; 2003 Mar; 55(2):203-8. PubMed ID: 12637098 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside. Li F; Wu G; Zheng H; Wang L; Zhao Z Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200 [TBL] [Abstract][Full Text] [Related]
16. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery. Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576 [TBL] [Abstract][Full Text] [Related]
18. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. Zou MJ; Cheng G; Okamoto H; Hao XH; An F; Cui FD; Danjo K World J Gastroenterol; 2005 Dec; 11(47):7457-60. PubMed ID: 16437716 [TBL] [Abstract][Full Text] [Related]
19. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes. Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064 [TBL] [Abstract][Full Text] [Related]
20. Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats. Dhaneshwar SS; Chail M; Patil M; Naqvi S; Vadnerkar G Eur J Med Chem; 2009 Jan; 44(1):131-42. PubMed ID: 18472188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]